Every finding on record at Bradley County Medical Center

. On 6/5/23 at 11:40 AM, an entrance conference was conducted with Agency Representatives. The Agency was informed the purpose of the visit was to conduct a Medicare Recertification survey for compliance with the Conditions of Participation for Home Health. On 5/8/23 at 10:35 AM an exit conference was conducted with Agency Representatives. Preliminary findings of the survey were discussed. .

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on Clinical Record review and staff interviews, it was determined the Skilled Nurse (SN) failed to include Oxygen (02) and Chemo Therapy (cancer treatment medicatons) during the review of the patients medications in 2 (#1 and #5) of 10 (#1 - #10) Clinical Records reviewed. This failed practice by the SN posed a risk of potential harm for patients that are using oxygen and receiving chemo therapy drugs by inhibiting the Nurse and Physician's ability to make informed decisions regarding the patients medication regimen related to potential adverse effects, drug reactions, significant side effects or significant drug interactions. Review of Clinical Record #1 revealed the following A. Document titled "Patient Medication Record" which showed Patient #1 was using oxygen (O2). There was no evidence the O2 was reviewed by the Agency for Potential adverse effects, drug reactions, significant side effects or significant drug interactions. B. During an interview with Agency staff on 6/8/23 at 9:30 A.M., Agency staff member #2 stated O2 was not checked for interaction. 2. Review of Clinical Record #5 revealed the following: A Document titled "Home Health Care Certification and Plan of Care" (POC) listed a diagnosis of pertainent diagnosis of Malignant neoplasm of lung (cancer of the lung). A review of a document titled "OASIS E Start of Care" showed the SN assessment and documentation of "Pt/CG [patient/caregiver] reports recent muscle weakness and repeated falls since starting chemo treatments last week." Review of a document titled "Client Medication Profile" showed no evidence Chemo drugs were listed and reviewed by the SN for potential advrse effects, drug reactions, significant side effects, or significant drug interactions. Further review of the POC listed O2 as supplies and durable medical eqipment for Patient #5 as well as orders for O2 precautions. There was no evidience the O2 was listed on the Client Medication Profile and reviewed for interactions. B. During an interview on 6/8/23 at 9:30 A.M. with Agency Staff, Agency Staff #2 stated the Chemo drugs nor the O2 were listed on the Medication Profile and were not reviewed by the SN for interactions.